StemCells, Inc. to Participate at Cantor Fitzgerald's Inaugural Healthcare Conference
01. Juli 2015 08:05 ET
|
StemCells, Inc.
NEWARK, Calif., July 1, 2015 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that management will make a presentation on the Company's programs, pipeline and operations at Cantor...
StemCells, Inc. Reports Top Line Results for Its Phase I/II Study in Dry Age Related Macular Degeneration
26. Juni 2015 10:00 ET
|
StemCells, Inc.
NEWARK, Calif., June 26, 2015 (GLOBE NEWSWIRE) -- StemCells, Inc. (NASDAQ:STEM), a leading stem cell company developing novel cell-based therapeutics for treating diseases and disorders of the central...
StemCells, Inc.'s Phase II Pathway Study for Cervical Spinal Cord Injury Approved by Health Canada
18. Juni 2015 08:05 ET
|
StemCells, Inc.
NEWARK, Calif., June 18, 2015 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), a world leader in the research and development of cell-based therapeutics for the treatment of central nervous system...
StemCells, Inc. Announces Commencement of the Second Cohort of the Pathway(TM) Study in Cervical Spinal Cord Injury
04. Juni 2015 08:05 ET
|
StemCells, Inc.
NEWARK, Calif., June 4, 2015 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), a world leader in the research and development of cell-based therapeutics for the treatment of central nervous system...
StemCells, Inc. Announces Closing of Over-Allotment Option
01. Juni 2015 16:05 ET
|
StemCells, Inc.
NEWARK, Calif., June 1, 2015 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) today announced that the underwriters of the Company's public offering that initially closed on April 29, 2015 have...
StemCells, Inc. to Participate at the 2015 Marcum MicroCap Conference
18. Mai 2015 08:05 ET
|
StemCells, Inc.
NEWARK, Calif., May 18, 2015 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that management will make a presentation on the Company's programs, pipeline and operations at the 2015...
StemCells, Inc. Announces Positive Top-Line Results of Its Thoracic Spinal Cord Injury Phase I/II Study
14. Mai 2015 08:30 ET
|
StemCells, Inc.
Sensory gains demonstrate the clinical effect of HuCNS–SC® transplantation
Results hold promise for Phase II PathwayTM cervical spinal cord injury study
NEWARK, Calif., May 14, 2015...
StemCells, Inc. Reports First Quarter 2015 Financial Results and Provides Business Update
05. Mai 2015 16:05 ET
|
StemCells, Inc.
NEWARK, Calif., May 5, 2015 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), a leading stem cell company developing and commercializing novel cell-based therapeutics for diseases of the central...
StemCells, Inc. Announces Webcast to Discuss First Quarter 2015 Financial Results
30. April 2015 17:27 ET
|
StemCells, Inc.
NEWARK, Calif., April 30, 2015 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), a leading stem cell company developing and commercializing novel cell-based therapeutics and tools for use in stem...
StemCells, Inc. Announces Closing of $25 Million Public Offering
29. April 2015 16:05 ET
|
StemCells, Inc.
NEWARK, Calif., April 29, 2015 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) today announced that it has closed its previously announced offering of common stock and warrants. The Company sold a...